BTOG2: A British Thoracic Oncology Group Phase III Trial Of Gemcitabine + Cisplatin at 80mg/m2 vs Gemcitibine + Cisplatin at 50mg/m2 vs Gemcitabine + Carboplatin AUC6 In stage IIIB/IV NSCLC (Extension)

Project Details

Short titleBTOG2: A British Thoracic Oncology Group Phase III Trial Of Gemcitabine + Cisplatin at 80mg/m2 vs Gemcitibine + Cisplatin at 50mg/m2 vs Gemcitabine + Carboplatin AUC6 In stage IIIB/IV NSCLC (Extension)
StatusActive
Effective start/end date1/09/0731/12/24

Funding

  • Cancer Research Uk
  • LILLY RESEARCH CENTRE LIMITED